Professor Eric Reynolds AO: Ledger

Stories naming Professor Eric Reynolds AO. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
CEO	Centre for Oral Health Research (COHR)	Brandon BioCatalyst portfolio
CEO · Founder	Oral Health CRC	Brandon BioCatalyst portfolio, Brandon Capital portfolio
Professor	University of Melbourne	Brandon BioCatalyst portfolio, Brandon Capital portfolio

Series A $14m

$14m invested in University of Melbourne spin-out to create vaccine for periodontal gum disease

A biotech spin-out from the University of Melbourne has raised a Series A to develop a gum disease vaccine, backed by a biomedical translation fund, a large biotech company and the university itself.

Brandon Capital portfolio Thu 26 Sep 2019 Denteric Brandon Capital Partners Centre for Oral Health Research (COHR)Cooperative Research Centres Program Medical Research Commercialisation Fund (MRCF)Melbourne Dental School Oral Health CRC Victorian Government Australian Government Biomedical Translation Fund CSL University of Melbourne Dr Andrew Nash Dr Chris Nave Professor Eric Reynolds AO Professor Jim McCluskey

Also Brandon BioCatalyst portfolio·Startup Daily·denteric.com·denteric.com·@AuManufacturing·Startup Daily

Professor Eric Reynolds AO

Roles

Coverage

$14m invested in University of Melbourne spin-out to create vaccine for periodontal gum disease